| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
calcium voltage-gated channel subunit alpha1 A | 0.489 | 0.769 | 1.00 |
|
disease | 0.760 | strong | 1.000 | 7 | 0 | 1996 | 2020 | ||||||||
|
calcium voltage-gated channel auxiliary subunit alpha2delta 2 | 0.626 | 0.615 | 1.00 |
|
disease | 0.510 | strong | 1.000 | 3 | 0 | 2002 | 2010 | ||||||||
|
calcium voltage-gated channel subunit alpha1 H | 0.628 | 0.423 | 4.8E-10 |
|
disease | 0.500 | None | 1.000 | 13 | 5 | 2003 | 2020 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit beta3 | 0.546 | 0.615 | 0.95 |
|
disease | 0.500 | None | 0.917 | 12 | 3 | 1999 | 2019 | ||||||||
|
Jrk helix-turn-helix protein | 0.612 | 0.500 |
|
disease | 0.420 | None | 1.000 | 3 | 0 | 1998 | 2001 | |||||||||
|
potassium two pore domain channel subfamily K member 9 | 0.615 | 0.577 | 0.96 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
EF-hand domain containing 1 | 0.659 | 0.231 | 1.9E-17 |
|
disease | 0.310 | None | 1.000 | 1 | 1 | 1994 | 1994 | ||||||||
|
hyperpolarization activated cyclic nucleotide gated potassium channel 1 | 0.564 | 0.654 | 1.00 |
|
disease | 0.230 | None | 1.000 | 4 | 1 | 2004 | 2020 | ||||||||
|
neuropeptide Y | 0.447 | 0.846 | 0.14 |
|
disease | 0.220 | None | 1.000 | 3 | 0 | 2013 | 2018 | ||||||||
|
solute carrier family 2 member 1 | 0.388 | 0.808 | 0.99 |
|
disease | 0.200 | None | 1.000 | 13 | 0 | 2006 | 2019 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit gamma2 | 0.548 | 0.654 | 0.74 |
|
disease | 0.200 | None | 1.000 | 13 | 3 | 2002 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 7 | 0.592 | 0.500 | 4.5E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta | 0.475 | 0.846 | 0.94 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
glutamate dehydrogenase 1 | 0.584 | 0.731 | 7.0E-03 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
calcium voltage-gated channel auxiliary subunit gamma 2 | 0.729 | 0.385 | 0.92 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
neuropeptide Y receptor Y5 | 0.691 | 0.462 | 6.4E-03 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
neuropeptide Y receptor Y2 | 0.612 | 0.577 | 3.6E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
neuropeptide Y receptor Y1 | 0.628 | 0.423 | 4.3E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit alpha1 | 0.563 | 0.577 | 0.91 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
NIPA magnesium transporter 2 | 0.805 | 0.192 | 0.92 |
|
disease | 0.030 | None | 1.000 | 3 | 1 | 2012 | 2019 | ||||||||
|
calcium voltage-gated channel subunit alpha1 G | 0.590 | 0.577 | 1.00 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2003 | 2017 | ||||||||
|
epilepsy, childhood absence 1 | 0.805 | 0.231 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1999 | 2002 | |||||||||
|
parvalbumin | 0.547 | 0.692 | 8.7E-02 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2019 | ||||||||
|
sodium voltage-gated channel alpha subunit 8 | 0.510 | 0.731 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2009 | 2015 |